Get research updatesBipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
A Double-Blind Placebo-Controlled Study of Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults With Bipolar Disorder, Major Depressive Disorder, Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
In CincinnatiA Dose Block-randomized, Double-blind, Placebo-controlled, Single Dose, Dose-escalation Study to Investigate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of Tolvaptan in Healthy Korean Male Subjects Bipolar Disorder
This study has finished and is no longer accepting participants.
In Seoul
Multinational Ambispective Study of the Clinical Management and Burden of Bipolar Disorder (WAVE bd Study)
This study has finished and is no longer accepting participants.
Multiple locations, including SalzburgA Nonrandomized, Open-Label, Multicenter, Phase 1 Study to Assess the Safety and Pharmacokinetics of ADASUVE® (STACCATO® Loxapine for Inhalation) at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication
This study has finished and is no longer accepting participants.
Multiple locations, including AtlantaThis study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In ItalyThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In ItalyThis study has finished and is no longer accepting participants.
In DallasA Randomized Open Label Study on the Efficacy, Tolerability, and Total Costs of Olanzapine Versus Conventional Antipsychotics in the Treatment of Acute Mania in Sweden
This study ended early.
In Danderyd
Repetitive Transcranial Magnetic Stimulation (rTMS) to Improve Cognitive Function and Prevent Relapses in Bipolar Patients
This study has finished and is no longer accepting participants.
In GuangzhouA Randomized, Double-blind, Placebo-controlled Study to Explore the Efficacy and Safety of Risperidone Long-acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolar 1 Disorder, With Open-label Extension
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study has finished and is no longer accepting participants.
In VancouverA Randomized, Double-Blind Study of Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness
This study ended early.
Multiple locations, including AnaheimWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.